---
- :edit_path: ''
  :tags_path: ''
  :status_path: "/iso_managed_v2/aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9TVFVEWV9PTkUvVjEjU1Q=/status?iso_managed%5Bcurrent_id%5D="
  :current_path: ''
  :delete_path: ''
  :show_path: ''
  :search_path: ''
  :list_cn_path: ''
  :impact_path: ''
  :clone_path: ''
  :build_path: "/studies/aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9TVFVEWV9PTkUvVjEjU1Q=/build"
  :indicators:
    :current: false
    :extended: false
    :extends: false
    :version_count: 0
    :subset: false
    :subsetted: false
  :crf_path: ''
  :acrf_path: ''
  :compare_path: ''
  :id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9TVFVEWV9PTkUvVjEjU1Q=
  :uri: http://www.transceleratebiopharmainc.com/STUDY_ONE/V1#ST
  :rdf_type: http://www.assero.co.uk/Protocol#Study
  :label: Study One
  :has_state:
    :id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9TVFVEWV9PTkUvVjEjU1RfUlM=
    :uri: http://www.transceleratebiopharmainc.com/STUDY_ONE/V1#ST_RS
    :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationState
    :registration_status: Incomplete
    :administrative_note: ''
    :effective_date: '2016-01-01T00:00:00+00:00'
    :until_date: '2016-01-01T00:00:00+00:00'
    :unresolved_issue: ''
    :administrative_status: ''
    :previous_state: Incomplete
    :multiple_edit: false
    :by_authority:
      :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvUkEjRFVOUzA3OTY1ODY4NA==
      :uri: http://www.assero.co.uk/RA#DUNS079658684
      :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationAuthority
      :organization_identifier: '079658684'
      :international_code_designator: DUNS
      :owner: true
      :ra_namespace:
        :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjVFJBTlNDRUxFUkFURQ==
        :uri: http://www.assero.co.uk/NS#TRANSCELERATE
        :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
        :short_name: Transcelerate
        :name: TransCelerate BioPharma Inc.
        :authority: www.transceleratebiopharmainc.com
  :has_identifier:
    :id: aHR0cDovL3d3dy50cmFuc2NlbGVyYXRlYmlvcGhhcm1haW5jLmNvbS9TVFVEWV9PTkUvVjEjU1RfU0k=
    :uri: http://www.transceleratebiopharmainc.com/STUDY_ONE/V1#ST_SI
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: STUDY ONE
    :version_label: ''
    :version: 1
    :semantic_version: 0.1.0
    :has_scope:
      :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjVFJBTlNDRUxFUkFURQ==
      :uri: http://www.assero.co.uk/NS#TRANSCELERATE
      :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
      :short_name: Transcelerate
      :name: TransCelerate BioPharma Inc.
      :authority: www.transceleratebiopharmainc.com
  :has_previous_version: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2021-01-20T09:58:14+01:00'
  :explanatory_comment: ''
  :description: ''
  :implements: 
